These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19715844)

  • 1. Inadequate mycophenolic acid exposure and acute rejection in kidney transplantation.
    Sánchez-Fructuoso AI; de la Higuera MA; Giorgi M; Ramos F; Garcia Ledesma P; Calvo N; Pérez-Flores I; Barrientos A
    Transplant Proc; 2009; 41(6):2104-5. PubMed ID: 19715844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft outcome and mycophenolic acid trough level monitoring in kidney transplantation.
    Sánchez Fructuoso AI; de la Higuera MA; Garcia-Ledesma P; Giorgi M; Ramos F; Calvo N; Pérez-Flores I; Barrientos A
    Transplant Proc; 2009; 41(6):2102-3. PubMed ID: 19715843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid.
    van Gelder T; Tedesco Silva H; de Fijter JW; Budde K; Kuypers D; Arns W; Soulillou JP; Kanellis J; Zelvys A; Ekberg H; Holzer H; Rostaing L; Mamelok RD
    Transplantation; 2010 Mar; 89(5):595-9. PubMed ID: 20124953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Ostrowska J; Gralak B; Majchrzak J
    Transplant Proc; 2006; 38(1):86-9. PubMed ID: 16504671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients.
    Mandla R; Midtvedt K; Line PD; Hartmann A; Bergan S
    Transpl Int; 2006 Jan; 19(1):44-53. PubMed ID: 16359376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
    Jain AB; Hamad I; Zuckerman S; Zhang S; Warty VS; Fung JJ; Venkataramanan R
    Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea.
    Lee S; Shin M; Kim E; Kim JM; Moon J; Jung G; Choi G; Kwon C; Joh J; Lee S; Kim S
    Transplant Proc; 2010 Apr; 42(3):793-6. PubMed ID: 20430174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.
    Kagaya H; Miura M; Saito M; Habuchi T; Satoh S
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):631-6. PubMed ID: 20136638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
    Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocol.
    Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; Hesse CJ; IJzermans JN; Weimar W
    Transpl Int; 2000; 13 Suppl 1():S333-5. PubMed ID: 11112026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycophenolic acid concentration profiles may select recipients with high-risk of acute rejection in renal transplant recipients].
    Kuriata-Kordek M; Boratyńska M; Urbaniak J; Woźniak M; Patrzałek D; Szyber P; Klinger M
    Pol Merkur Lekarski; 2006 Aug; 21(122):161-3; discussion 164. PubMed ID: 17144102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian pharmacokinetics of mycophenolic Acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients.
    Satoh S; Tada H; Murakami M; Tsuchiya N; Li Z; Numakura K; Saito M; Inoue T; Miura M; Hayase Y; Suzuki T; Habuchi T
    Transplantation; 2006 Aug; 82(4):486-93. PubMed ID: 16926592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA.
    Alvarez-Elías AC; Yoo EC; Todorova EK; Singh RN; Filler G
    Ther Drug Monit; 2017 Jun; 39(3):220-228. PubMed ID: 28437284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic acid concentrations are associated with cardiac allograft rejection.
    DeNofrio D; Loh E; Kao A; Korecka M; Pickering FW; Craig KA; Shaw LM
    J Heart Lung Transplant; 2000 Nov; 19(11):1071-6. PubMed ID: 11077224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience.
    Rhu J; Lee KW; Park H; Park JB; Kim SJ; Choi GS
    Ann Transplant; 2017 Nov; 22():707-718. PubMed ID: 29180612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.